Thyroid cancer starts in the cells of your thyroid gland, a small organ at the base of your neck that produces hormones to control metabolism and growth
Most thyroid cancers grow slowly and have a good outlook when caught early, but the type of cancer, how far it has spread, and your age all affect the course of the disease and what happens next. The thyroid is about the size of a walnut and sits just below your Adam's apple. When cells in this gland begin to grow abnormally, they can form a tumor that may stay in the thyroid or spread to lymph nodes and other parts of the body.
Thyroid cancer is not one disease but several different diseases, each with its own growth pattern and treatment path. Understanding which type you or someone you know has been diagnosed with matters because it shapes what doctors recommend and what to expect over time.
Key Takeaways
- Thyroid cancer develops when cells in the thyroid gland grow abnormally, and there are four main types—papillary, follicular, medullary, and anaplastic—each with different growth rates and treatment paths.
- Most people with thyroid cancer have no symptoms at first; the cancer is often found during imaging for another reason or when a doctor feels a lump during a routine exam.
- Risk factors include radiation exposure (especially in childhood), a family history of thyroid cancer, and certain genetic conditions, though many people with thyroid cancer have no known risk factors.
- Diagnosis involves blood tests, ultrasound imaging, and sometimes a biopsy where a small sample of thyroid tissue is examined under a microscope.
- Treatment usually begins with surgery to remove part or all of the thyroid, and may include radioactive iodine therapy or external radiation depending on the type and stage.
The four main types of thyroid cancer and how they differ
Papillary thyroid cancer is the most common type, accounting for about 80 percent of all thyroid cancers. It grows slowly and usually stays in the thyroid or nearby lymph nodes in the neck. Even when it spreads to lymph nodes, people often do well with treatment. Papillary cancer is also the least likely to return after treatment.
Follicular thyroid cancer makes up about 10 to 15 percent of cases. It grows slowly like papillary cancer but is more likely to spread to bones and lungs. It is less likely to spread to lymph nodes in the neck. Follicular cancer is slightly more aggressive than papillary, but the outlook is still generally good with treatment.
Medullary thyroid cancer accounts for 3 to 4 percent of thyroid cancers. It arises from cells that produce a hormone called calcitonin. About one-quarter of medullary cases run in families as part of a genetic syndrome. This type can spread to lymph nodes and distant organs earlier than papillary or follicular cancer.
Anaplastic thyroid cancer is the rarest and most aggressive type, making up 1 to 2 percent of cases. It grows quickly and spreads fast. Because it is found at a later stage in most people, the outlook is more serious than with the other types. However, newer treatments are changing outcomes for some patients.
Why thyroid cancer develops: known and unknown causes
Radiation exposure is the strongest known risk factor for thyroid cancer, especially when exposure happens in childhood. This includes medical radiation from repeated X-rays, CT scans, or radiation therapy to the head, neck, or chest. People exposed to radiation from nuclear accidents or weapons testing also have higher risk. The risk rises with the dose and decreases with time since exposure, but can remain elevated decades later.
A family history of thyroid cancer or certain genetic conditions increases risk. People with familial adenomatous polyposis (FAP), Cowden syndrome, or a family history of medullary thyroid cancer face higher odds. Genetic testing can identify some of these conditions before cancer develops, which matters because people with medullary thyroid cancer in the family may benefit from preventive surgery.
Other factors associated with thyroid cancer include female sex (women are diagnosed three times more often than men, though men tend to have worse outcomes), existing thyroid disease, and obesity. Hormonal factors may play a role—pregnancy, recent childbirth, and estrogen use have been studied, but the evidence is mixed. Many people diagnosed with thyroid cancer have none of these risk factors, which means the disease can occur without an obvious cause.
How thyroid cancer is usually found
Most people with thyroid cancer have no symptoms when the cancer is discovered. A doctor may feel a lump or nodule in the thyroid during a routine neck exam, or imaging done for another reason—such as a CT scan or ultrasound of the neck—may show an abnormal area. Some people notice a lump themselves and bring it to their doctor's attention.
Less commonly, thyroid cancer causes symptoms like a lump that grows quickly, pain in the front of the neck, difficulty swallowing, hoarseness, or swollen lymph nodes. These symptoms can also be caused by non-cancerous thyroid conditions, so they do not automatically mean cancer is present. A doctor will order tests to determine what is causing the symptoms.
The steps from finding a nodule to diagnosis
When a nodule is found, the first step is usually an ultrasound of the thyroid. The ultrasound shows the size, shape, and texture of the nodule and whether other nodules are present. Some nodules look suspicious for cancer based on their appearance on ultrasound; others look benign. The radiologist will describe what they see using a standardized system.
If the nodule looks suspicious or is large, a biopsy is the next step. A doctor uses ultrasound to guide a thin needle into the nodule and removes a small sample of cells. This is called a fine-needle aspiration biopsy. The sample goes to a pathologist, who looks at the cells under a microscope to determine whether cancer is present. The biopsy result falls into one of several categories that guide the next decision—some results are clearly benign or clearly cancer, while others are uncertain and may require repeat biopsy or surgery to know for sure.
Blood tests may also be ordered. A test for thyroid-stimulating hormone (TSH) checks how the thyroid is functioning. For medullary thyroid cancer, a blood test for calcitonin levels can help with diagnosis and monitoring. These tests do not diagnose cancer on their own but provide information that guides other decisions.
What happens after thyroid cancer is diagnosed
Once thyroid cancer is confirmed, imaging tests determine whether the cancer has spread beyond the thyroid. A CT scan or radioactive iodine scan may be used, depending on the type of cancer. The extent of spread—called the stage—affects treatment decisions and outlook.
Surgery to remove the thyroid (called thyroidectomy) is the main treatment for most thyroid cancers. The surgeon removes the entire thyroid or part of it, depending on the type of cancer and how far it has spread. Lymph nodes in the neck may also be removed if they contain cancer. After surgery, many people need radioactive iodine therapy, which uses a radioactive form of iodine that the thyroid cells absorb and destroy. This therapy is used mainly for papillary and follicular cancers.
External beam radiation therapy may be recommended if the cancer is anaplastic, has spread to distant organs, or did not respond to other treatments. Newer targeted therapies and immunotherapies are also available for certain types of thyroid cancer, particularly anaplastic cancer. After initial treatment, people have regular follow-up appointments and blood tests to watch for recurrence.
Living with thyroid cancer and long-term outlook
The outlook for thyroid cancer varies widely depending on the type, stage at diagnosis, and age at diagnosis. Papillary and follicular thyroid cancers have five-year survival rates above 95 percent when all stages are combined. Medullary thyroid cancer has a five-year survival rate around 98 percent overall, though outcomes depend on stage. Anaplastic thyroid cancer is more serious, with a five-year survival rate around 10 percent, but newer treatments are improving these numbers for some patients.
After treatment, most people with papillary or follicular thyroid cancer live normal lifespans. They will need to take thyroid hormone replacement for life because the thyroid has been removed or destroyed. Regular blood tests and imaging monitor for recurrence, which can happen years or even decades after initial treatment. Many people have no recurrence and can eventually space out their follow-up visits.
Side effects from treatment vary. Surgery can affect the voice if nerves are damaged, or cause low calcium levels if the parathyroid glands are affected. Radioactive iodine can cause dry mouth or change taste. Most side effects are manageable, and many improve over time. Support groups and conversations with other people who have had thyroid cancer can help with adjustment and questions about life after treatment.
Frequently Asked Questions
Can a thyroid nodule turn into cancer?
Not all nodules are cancer, and most nodules never become cancer. A nodule that is benign will remain benign. However, some nodules do contain cancer cells, which is why doctors recommend imaging and sometimes biopsy when a nodule is found. The appearance on ultrasound and the biopsy result help determine the actual risk.
Is thyroid cancer hereditary?
Most thyroid cancer is not hereditary, but medullary thyroid cancer can run in families as part of genetic syndromes like multiple endocrine neoplasia type 2 (MEN2). If you have a family history of medullary thyroid cancer or these syndromes, genetic testing and counseling can help determine your risk and guide screening or prevention.
What does radioactive iodine therapy do?
Radioactive iodine is absorbed by thyroid cells and destroys them from the inside. It is used after surgery to destroy any remaining thyroid tissue and any thyroid cancer cells that may have spread to other parts of the body. The radioactivity is cleared from your body over days to weeks, and the treatment is generally well-tolerated.
Will I need to take medication after thyroid cancer treatment?
Yes. After the thyroid is removed or destroyed, you will need to take synthetic thyroid hormone (levothyroxine) for life to replace the hormone your thyroid no longer produces. Your doctor will adjust the dose based on blood tests to keep hormone levels in the right range.
Can thyroid cancer come back after treatment?
Yes, thyroid cancer can recur, though the risk varies by type and stage. Papillary and follicular cancers recur in a small percentage of people, sometimes years or decades after treatment. This is why long-term follow-up with blood tests and imaging is recommended. Recurrence does not mean treatment failed—it can often be treated successfully again.